People with neuromyelitis optica spectrum disorder (NMOSD) who smoke have a higher risk of incomplete recovery after disease relapses…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Acute attacks of neuromyelitis optica spectrum disorder (NMOSD) may be worsened by web-like structures released by immune cells that…
A simple blood test measuring the levels of three proteins linked to brain damage and inflammation may help guide management…
Treatment with Soliris (eculizumab) substantially reduces the risk and frequency of relapses in adults with neuromyelitis optica spectrum…
An international team of researchers has identified three genetic variants significantly associated with higher odds of developing neuromyelitis optica…
Measuring the blood levels of natural killer (NK) cells, a type of immune cell, may serve as a diagnostic biomarker…
Depletion of sex hormone production by surgical removal of the ovaries significantly lessened activation of microglia — the brain’s immune…
Specific nerve damage and shrinkage in key brain regions are associated with a faster time to relapse and worsening disability…
A specific set of immune-related genes is significantly more active in the blood of people with neuromyelitis optica spectrum…
Newer, more potent therapies offer greater benefit than standard immunosuppressants in reducing relapse rates for people who develop neuromyelitis…